Helen Heslop

36PUBLICATIONS
144CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|May 28, 2026
A reassessment of anti-CAR T-cell expansion strategies.

|Mar 05, 2026
Introduction to a review series on hemophagocytic lymphohistiocytosis.

Helen E Heslop, Jorge Di Paola

|Jan 02, 2026
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial.

Benjamin L Musher, Spyridoula Vasileiou, Brandon G Smaglo

|Feb 17, 2025
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma.

Che-Hsing Li, Sandhya Sharma, Andras A Heczey

|Feb 05, 2025
Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas.

Yomani D Sarathkumara, Nathan W Van Bibber, Zhiwei Liu

|Nov 28, 2024
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers.

David Steffin, Nisha Ghatwai, Antonino Montalbano

Pageof 6

Frequent Collaborators

12 joint publications

Thao Wang

8 joint publications

Premal Lulla

7 joint publications

Carlos Ramos

5 joint publications

Andras Heczey